MB
MPM BioImpact’s ALX Oncology ALXO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-550,000
| Closed | -$343K | – | 45 |
|
|
2025
Q1 | $343K | Sell |
550,000
-841,434
| -60% | -$524K | 0.06% | 43 |
|
|
2024
Q4 | $2.32M | Sell |
1,391,434
-1,018,428
| -42% | -$1.7M | 0.33% | 46 |
|
|
2024
Q3 | $4.39M | Buy |
2,409,862
+228,998
| +11% | +$417K | 0.66% | 39 |
|
|
2024
Q2 | $13.2M | Buy |
2,180,864
+912,393
| +72% | +$5.5M | 2.04% | 16 |
|
|
2024
Q1 | $14.1M | Buy |
1,268,471
+3,712
| +0.3% | +$41.4K | 2.27% | 15 |
|
|
2023
Q4 | $18.8M | Buy |
+1,264,759
| New | +$18.8M | 4.41% | 6 |
|